Stay updated on Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Sign up to get notified when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.

Latest updates to the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedMajor update to page content with new government status notice and NIH Clinical Center operating status, plus version bump to v3.2.0; removal of a specific genetic disease resource (Multiple myeloma) and downgrade from v3.1.0 to v3.1.0.SummaryDifference3%
- Check20 days agoChange DetectedCore term updated from Plasma cell myeloma to Multiple myeloma; new version v3.1.0; added identifier/phone-like number 6779 5555.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed, which is a minor UI change; no other substantive content changes were detected.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has added significant information regarding the facility name and location, as well as detailed content related to plasma cell myeloma and various chemical compounds. However, it has removed several related topics and terms that may have previously provided context about multiple myeloma and its treatments.SummaryDifference7%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.